Full text is available at the source.
Abstract
A single injection of ketamine at 6 or 10 mg/kg significantly reduced immobility in the tail suspension test 24 hours after treatment.
- Both subanesthetic doses of ketamine produced similar acute antidepressant-like effects in stressed mice.
- The reduction in immobility was not sustained one week after treatment.
- Molecular analyses showed dose- and region-dependent regulation of signaling markers in the prefrontal cortex, hippocampus, and striatum.
- The higher ketamine dose resulted in more extensive molecular changes without a corresponding increase in behavioral improvement.
- The findings suggest that the effects of ketamine on behavior may depend on specific brain regions rather than the overall activation level of molecular pathways.
Simplified